Publications

OPAT PUBLICATIONS

OPAT versus inpatient care in the UK: a health economic assessment for six key diagnoses.

BSAC & Scottish Health Technologies Group (SHTG) recommendations. BSAC and the Scottish Antimicrobial Prescribing Group (SAPG) invited SHTG to review the use of OPAT in Scotland. BSAC is pleased to endorse findings and recommendations published by Health Improvement Scotland.

 

DRUG STABILITY

PUBLISHED MANUSCRIPT: Assessment of ceftolozane/tazobactam stability in elastomeric devices and suitability for continuous infusion via outpatient parenteral antimicrobial therapy.
Authors: Conor Jamieson, Felicity Drummond, Tim Hills, Laima Ozolina, Mark Gilchrist, R Andrew Seaton, Mark Santillo, Alan-Shaun Wilkinson, Michael C Allwood.
Journal: JAC-Antimicrobial Resistance, Volume 3, Issue 3, September 2021 (https://doi.org/10.1093/jacamr/dlab141).

PUBLISHED MANUSCRIPT: Assessment of the stability of citrate-buffered piperacillin/tazobactam for continuous infusion when stored in two commercially available elastomeric devices for outpatient parenteral antimicrobial chemotherapy: a study compliant with the NHS Yellow Cover Document requirements.
Authors: Conor Jamieson, Laima Ozolina, R Andrew Seaton, Mark Gilchrist, Tim Hills, Felicity Drummond, Alan-Shaun Wilkinson, on behalf of the BSAC Drug Stability Testing Working Group.
Journal: European Journal of Hospital Pharmacy online (http:// dx. doi. org/ 10. 1136/ ejhpharm- 2020- 002340).

PUBLISHED MANUSCRIPT: Investigation of meropenem stability after reconstitution: the influence of buffering and challenges to meet the NHS Yellow Cover Document compliance for continuous infusions in an outpatient setting.
Authors: Conor Jamieson, Michael Charles Allwood, Donata Stonkute, Andrew Wallace, Alan-Shaun Wilkinson, Tim Hills, on behalf of the BSAC Drug Stability Working Party.
Journal: European Journal of Hospital, 2018;0:1–5. doi:10.1136/ejhpharm-2018-001699.

PUBLISHED MANUSCRIPT: Assessment of the stability of citrate-buffered flucloxacillin for injection when stored in two commercially available ambulatory elastomeric devices: INfusor LV (Baxter) and Accufuser (Woo Young Medical): a study compliant with the NHS Yellow Cover Document (YCD) requirements.
Authors: Michael Charles Allwood, Donata Stonkute, Andrew Wallace, Alan-Shaun Wilkinson, Tim Hills, and Conor Jamieson on behalf of the BSAC Drug Stability Working Party.
Journal: European Journal of Hospital, 2018. 0:1–5. doi:10.1136/ejhpharm-2018-001515.

PUBLISHED MANUSCRIPT: Extended stability of antimicrobial agents in administration devices
Author: Abi Jenkins; Tim Hills; Mark Santillo; Mark Gilchrist; Journal of Antimicrobial Chemotherapy 2017; doi: 10.1093/jac/dkw556.

Presented at the BSAC OPAT Conference, 11th December 2019

POSTER: Piperacillin/tazobactam
Piperacillin/tazobactam POSTER
Title: Assessing the stability of piperacillin/tazobactam at 25 mg/mL and 90 mg/mL reconstituted and diluted in 0.3% w/v citrate buffered saline in two commercially available elastomeric devices.
Authors: Conor Jamieson, Felicity Drummond, Laima Ozolina and Alan-Shaun Wilkinson, on behalf of the UK OPAT Initiative Drug and Stability Working Group.

POSTER: Cefatzidime
Cefatzidime POSTER
Title: Stability testing of ceftazidime solutions for injection in elastomeric devices at 12 mg/mL and 25 mg/mL in 0.9% w/v saline for safe use in Outpatient Parenteral Antimicrobial Therapy (OPAT).
Authors: Conor Jamieson, Felicity Drummond, Laima Ozolina and Alan-Shaun Wilkinson, on behalf of the UK OPAT Initiative Drug and Stability Working Group.

POSTER: Ceftolozane/tazobactam
Ceftolozane/tazobactam POSTER
Title: Assessing the stability of ceftolozane/tazobactam (ZERBAXA®) at 5 mg/mL and 20 mg/mL following reconstitution and dilution in 0.9% saline in two commercially available elastomeric devices.
Authors: Conor Jamieson, Felicity Drummond, Laima Ozolina and Alan-Shaun Wilkinson, on behalf of the UK OPAT Initiative Drug and Stability Working Group.

Presented at the BSAC OPAT Conference, 13th-14th December 2018

POSTER: OPAT flow rate
Title: Outcomes of a National Survey of Experience with Continuous Infusion Elastomeric Devices in OPAT.
Authors: Tim Hills, Conor Jamieson, Mark Gilchrist, Carolyne Horner, Andrew Seaton, on behalf of the UK OPAT Initiative Drug and Stability Working Group.

Presented at the BSAC OPAT Conference, 11th-12th December 2017

POSTER: Flucloxacillin
Title: Assessment of the stability of citrate-buffered Flucloxacillin for injection when stored in two commercially available ambulatory devices: INfusor (Baxter) and Accufuser® (Woo Young Medical), a study compliant with the NHS Yellow Cover Document (YCD) requirements.
Authors: Tim Hills MRPharmS Michael Charles Allwood PhD, Donata Stonkute BSc, Andrew Wallace PhD, Alan-Shaun Wilkinson PhD, on behalf of the BSAC Drug Stability Working Party.

POSTER: Meropenem
Title: The influence of pH and buffering on the stability of Meropenem 6.25-25 mg/ml at 32C.
Authors: Tim Hills MRPharmS Michael Charles Allwood PhD, Donata Stonkute BSc, Andrew Wallace PhD, Alan-Shaun Wilkinson PhD, on behalf of the BSAC Drug Stability Working Party.

DOCUMENT: OPAT Guidance
Title: Guidance on the pharmaceutical issues concerning OPAT Services and other outpatient intravenous therapies.
Authors: Mark Santillo, Abi Jenkins, Conor Jamieson on behalf of the NHS Pharmaceutical Quality Assurance Committee.

 


 

GOOD PRACTICE RECOMMENDATIONS

Updated good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults and children in the UK (Full recommendations)
Leader Article in JAC: Outpatient parenteral antimicrobial therapy: updated recommendations from the UK

An assessment tool has been provided for you to assess your OPAT service against the updated Good Practice Recommendations. The tool is provided as an Excel sheet (for electronic completion) and as a pdf (for printing).

BSAC are interested in your thoughts about the updated OPAT Good Practice Recommendations. Watch this space for news of a survey that will collect thoughts and experiences.

Earlier versions of the OPAT Good Practice Recommendations
Good practice recommendations for Outpatient Parenteral Antimicrobial Therapy (OPAT) in adults in the UK: a consensus statement

Good practice recommendations for Paediatric Outpatient Parenteral Antibiotic Therapy (P-OPAT) in the UK: a consensus statement

PAEDIATRIC SUPPORT RESOURCES
The following resources are reproduced with the kind permission of Southampton Children’s Hospital OPAT Service.

Parent-carer-PICC-guidance
Infusion-Aseptic-No-Touch-technique
Parent-carer-CVC-guidance
Hand-washing-technique
Ground-rules-for-parents-carers
Competency-checklist-for-parents-carers
Community-Nurse-Template
Cribb-sheet-for-registrars
Bolus-dose-Aseptic-No-Touch-Technique

Inclusion of the above resources does not imply BSAC endorsement or approval
HOW IS INCOME GENERATED BY OUTPATIENT PARENTERAL ANTIBIOTIC TREATMENT (OPAT) IN THE UK? Analysis of payment tariffs for cellulitis